Seeking Alpha

madhastings

madhastings
Send Message
View as an RSS Feed
View madhastings' Comments BY TICKER:
Latest  |  Highest rated
  • For Ekso, Military Could Prove To Be A Secondary Market With Deep Pockets [View article]
    EKSO's exoskeleton was featured on 60 mins Overtime, Nov. 9th. They even referred to as "exoskeleton" in the piece, it is my opinion that they misspelled "exo." I verified that 60 mins showed up under EKSOBIONICS.com Investor News and cross-verified that it did NOT show up on RWLK's. Finally, EKSO is starting to make the news, get some attention.

    http://cbsn.ws/1103gjq
    Nov 12, 2014. 02:27 PM | Likes Like |Link to Comment
  • For Ekso, Military Could Prove To Be A Secondary Market With Deep Pockets [View article]
    Nice "EKSO Update" article in Total Wealth:
    http://bit.ly/1zEmbz5
    Nov 9, 2014. 10:01 AM | Likes Like |Link to Comment
  • American Vanadium Is The Watch List Stock Of The Year [View article]
    The first "sale" of CellCube = 8/14/14 - CO facility, 6 months after proof of concept. So, if that math holds, we should see a second sale to NY's MTA in Nov, 2014. FYI - google finance tends to provide the best source of articles about AVCVF.

    http://on.mktw.net/1s4...
    Sep 14, 2014. 11:35 AM | 1 Like Like |Link to Comment
  • For Ekso, Military Could Prove To Be A Secondary Market With Deep Pockets [View article]
    EKSO has $10.97 Million in cash and only $140k in debt. I am not sure why you think that's bad.
    Sep 12, 2014. 05:46 PM | Likes Like |Link to Comment
  • 3 Lessons From The Galena Scandal [View article]
    First, thank you so much, Mr. Pearson, for sharing your thoughts and findings on GALE. I was long GALE when I read your first article re: the Dream Team and GALE management's involvement in those articles - and held to my chagrin, because I believed in the science of NeuVax. I agreed with you then that investing in companies with management credibility issues is a big mistake, but I went against my better judgment and invested anyway. Now, I am out, essentially at break-even, and waiting for GALE to drop more due to: A) dilution, and B) another shoe dropping with SEC investigation as the only reason Ahn "resigned" (most likely forced out) was a pre-emptive measure.

    I am curious, if you have read the seekingalpha article: "Oncologist's Perspective," and what you thought of his credibility and/or findings? I invested in GALE largely based on that article, as I found it to be very convincing.
    Aug 25, 2014. 02:22 PM | Likes Like |Link to Comment
  • Galena secures U.S. rights to serotonin blocker [View news story]
    I think it is smart a smart move on GALE management's part to add to their revenue stream during clinical trials. Happy to see them doing smart things and starting to regain their credibility along with adding to their revenue.
    Jul 22, 2014. 10:22 AM | Likes Like |Link to Comment
  • Galena Biopharma: The Oncologist's Perspective On A Life Saving Therapy [View article]
    I second Mr. Oda's comments and would like to add my thanks. As an Oncologist (who is not on GALE's payroll) you spoke with much needed credibility and authority on the subject of NeuVax.
    Jun 24, 2014. 08:00 PM | Likes Like |Link to Comment
  • Neuralstem And Brainstorm Cell Therapeutics: The Race To Treat ALS [View article]
    Thank you so much for the beautifully written article and expert analysis.
    I like both BCLI and CUR. I am currently long BCLI and looking for an opportunity to go long CUR as I like both therapies and sincerely hope that they prove effective in fighting ALS for the patients' sakes.
    Jun 12, 2014. 01:17 PM | Likes Like |Link to Comment
  • Neuralstem And Brainstorm Cell Therapeutics: The Race To Treat ALS [View article]
    BCLI is dosing its first US patient in the US at Mass General in Boston.

    http://bit.ly/1xP2RfW
    Jun 12, 2014. 01:06 PM | Likes Like |Link to Comment
  • Galena: Setting The Record Straight [View article]
    I am keeping my fingers crossed for positive Phase III results of Neuvax due out soon for cancer patients that would benefit from a breakthrough drug and the longs.
    Jun 10, 2014. 06:17 PM | Likes Like |Link to Comment
  • American Vanadium Is The Watch List Stock Of The Year [View article]
    Thanks for your article. I am thinking about investing a little in American Vanadium. An update, (probably aware of) is:

    "American Vanadium Announces First Cellcube Vanadium Flow Battery Installation In America

    February 19, 2014 - AMERICAN VANADIUM CORP. ("American Vanadium" or the "Company") (AVC.V) (OTCQX:AVCVF) announces that the US Department of Energy's National Renewable Energy Laboratory ("NREL") will evaluate and demonstrate the CellCube vanadium redox flow energy storage system at its state-of-the-art testing facility. After the demonstration of the energy storage system at NREL's facility in Golden, Colorado, the CellCube is designated for sale to a US utility."

    http://yhoo.it/1dD9llO
    Mar 23, 2014. 07:56 AM | Likes Like |Link to Comment
  • Oil Search to raise $1.1B to buy Papua New Guinea gas assets [View news story]
    Thanks for laying out the deal components in such an "easy to understand" fashion.
    Feb 27, 2014. 09:18 AM | Likes Like |Link to Comment
  • Mazor Robotics: The Medical Renaissance Is Underway [View article]
    Q4, so far, Mazor has booked 5 sales, aka erasing Q3 revenue issues, which means their revenues will be coming in at the top end of forecasts/estimates. I would not be surprised to see them book another sale, which would mean that they would beat estimates.

    MZOR brain surgery was already launched in 2013. http://yhoo.it/1exwqfc

    MZOR raised $43 million this year to increase their sales and marketing efforts n the USA, that is substantial and we should see the positive effects 2nd half of 2014.

    Happy Holidays All!
    Dec 22, 2013. 10:50 AM | 1 Like Like |Link to Comment
COMMENTS STATS
13 Comments
2 Likes